Status In progress
Process HST
ID number 861

Provisional Schedule

Expected publication 26 September 2018

Project Team

Project lead Joanne Ekeledo

Email enquiries


Companies sponsors Aegerion Pharmaceuticals Ltd
Others Department of Health
  NHS England
Patient carer groups Diabetes UK
  Lipodystrophy UK
Professional groups Royal College of Physicians


Comparator companies None
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Health Improvement Scotland
  Welsh Government
  Welsh Health Specialised Services Committee


Key events during the development of the guidance:

Date Update
08 November 2017 Invitation to participate
21 April 2017 Referral
21 April 2017 In progress, Topic referred
21 November 2016 - 19 December 2016 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

For further information on how we develop guidance, please see our page about NICE highly specialised technologies guidance